
KLBF
Detail Analisis & Profil Saham
Deep AI Analysis
Login untuk Analisis AIAI sedang menyusun analisis mendalam untuk KLBF...
Analisis AI Membutuhkan Login
Silakan masuk (login) ke akun Sentix gratis untuk men-generate dan melihat analisis AI mendalam untuk saham KLBF.
Masuk / Daftar SekarangTentang Perusahaan
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Jajaran Direksi
Struktur Kepemilikan
Valuasi Utama
Data Keuangan & Metrik
Indikator Momentum
Volume & Tren MA
Berita Terkini
IHSG masih dibayangi koreksi, simak rekomendasi saham INKP, KLBF, RAJA, dan AADI
IHSG Bakal Melambung, Cermati Rekomendasi Saham Analis 9 Oktober 2026
Cermati rekomendasi saham INKP, KLBF, RAJA dan AADI untuk perdagangan Jumat (9/10)
IHSG Tersungkur, tapi 4 Saham Mentok ARA hingga 24%
Indeks Bisnis-27 Dibuka Menguat, Saham KLBF, DEWA dan BUMI Melaju
IHSG Berpeluang Melemah ke 6.400, Cek Rekomendasi Saham 21 September 2026
KLBF Hingga MBMA Gelar Buyback, Mana Sahamnya yang Bisa Dilirik?
Kalbe (KLBF) Rencana Buyback Saham Rp500 Miliar Mulai Hari Ini
KLBF siap gelar buyback saham maksimal Rp500 miliar
Kalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National Scale
Emiten Farmasi (KLBF) Mau Buyback Saham, Siapkan Dana Rp 250 M
#saham klbf
Tidak ada berita Nasional terbaru.
Tidak ada berita Global terbaru.